Antidepressant Potential of Species from the Piperaceae Family: A Comprehensive Review of Preclinical Studies
DOI:
https://doi.org/10.34119/bjhrv8n5-184Keywords:
Piperaceae, depression, animal, central nervous systemAbstract
The Piperaceae family is recognized for its ethnopharmacological relevance and diversity of secondary metabolites. Several species, such as Piper nigrum, Piper methysticum and Piper longum, have been traditionally used for their effects on the central nervous system, sparking growing scientific interest regarding their therapeutic potential. Thus, the present study aims to review published works on natural and synthetic compounds from the Piperaceae family with proven antidepressant activity. Methods: A bibliographic survey was conducted covering the period from 2000 to 2025 in the Web of Science, PubMed, and Science Direct databases. The descriptors “Piperaceae” and “depression” (Portuguese and English terms) were used. After title and abstract screening, 43 articles were initially selected, and following eligibility criteria, 18 articles were retained for full-text review. Results: Piper nigrum, Piper longum and Piper sarmentosum were the most investigated species regarding their potential antidepressant effects, acting on several systems such as serotonergic, GABAergic, and monoamine oxidase enzymes. All studies were conducted in animal models of depression, employing isolated substances, extracts, and essential oils. Conclusion: Preclinical studies highlight species of the Piperaceae family as promising alternatives for antidepressant treatment, given their abundance in nature. However, further studies in other species, as well as clinical trials, are warranted.
References
*Articles selected for the literature review
ANAND, R. et al. Piperine, a major constituent of black pepper, protects against neurodegeneration in an animal model of Parkinson’s disease. Neurochemical Research, v. 41, n. 9, p. 2510-2520, 2016. doi: https://doi.org/10.1007/s11064-016-1968-1
* BASAVARAJU, S.; MUDHOL, S.; PEDDHA, M. et al. Nanoemulsion-based piperine to enhance bioavailability for the treatment of LPS-induced depression-like behaviour in mice. Neuroscience Letters, v. 814, 137441, 2023. https://doi.org/10.1016/j.neulet.2023.137441.
BOERNER, R., SOMMER, H., BERGER, W. Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Phytomedicine. v.10, p. 38-49, 2003. doi: 10.1078/1433-187x-00309. PMID: 12807341.
* CHAVARRIA, D.; SILVA, T.; MAGALHÃES E SILVA, D et al. Lessons from black pepper: piperine and derivatives thereof. Expert Opinion on Therapeutic Patents, v. 26, n.2, p. 245-264, 2016. doi:10.1517/13543776. 2016.1118057. PMID: 26560940.
* CHOTRITTHIRONG, Y.; CHULIKHIT, Y.; DAODEE, S. et al (2023). Possible mechanisms for the prevention of anxiety and depressive-like behavior in a chronic mild stress mouse model by the thai herbal medicine with Nelumbo nucifera, Centella asiatica, and Piper nigrum. Revista Brasileira de Farmacognosia, v.33, p. 756–767, 2023. https://doi.org/10.1007/s43450-023-00401-x
DHINGRA, D.; JOSHI, P.; GUPTA, A.; CHHILLAR, R. Possible involvement of monoaminergic neurotransmission in antidepressant-like activity of emblica officinalis fruits in mice. CNS Neuroscience and Therapeutics, v. 18, p. 419 – 425, 2011.
* FELIPE, F.; FILHO, J; SOUZA, L. et al. Piplartine, an amide alkaloid from Piper tuberculatum, presents anxiolytic and antidepressant effects in mice. Phytomedicine, v.14, p. 605 – 612, 2007. https://doi.org/10.1016/j.phymed.2006.12.015
FRIED, E.; FLAKE, J.; ROBINAUGH, D (2022). Revisiting the theoretical and methodological foundations of depression measurement. Nature Reviews Psychology, v. 1, p. 358–368, 2022.
GARCIA, G. et al. Piper hispidum: A source of butenolides with agonistic activity at serotonin receptors 5-HT1A and 5-HT7, 2013. Journal of Natural Products, v. 76, n. 9, p. 1806-1812. doi: 10.1021/np400370e
GALECKI, P.; TALAROWSKA, M. The Evolutionary Theory of Depression. Medical Science Monitor, v. 23, p. 2267 – 2274, 2017.
GASTPAR, M., KLIMM, H. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial. Phytomedicine. v. 10, n.8, p.631-639, 2003. doi: 10.1078/0944-7113-00369. PMID: 14692723.
GODLEWSKA, B.; HARMER, C. Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment. Psychopharmacology, v. 238, p.1265–1278, 2021.
* GOSH, S.; KUMAR, A.; SACHAN, N.; CHANDRA, P. Anxiolytic and antidepressant-like effects of essential oil from the fruits of Piper nigrum Linn. (Black pepper) in mice: involvement of serotonergic but not GABAergic transmission system. Heliyon, v.7, e06884, 2021. https://doi.org/10.1016/j.heliyon.2021.e06884
GUAN, D.; HOU, Z.; FAN, B., et al . The extract of Piper nigrum improves the cognitive impairment and mood in sleep-deprived mice through the JAK1/STAT3 signalling pathway. International Journal of Molecular Sciences, v. 26, n.5, 1842, 2025. https://doi.org/10.3390/ijms26051842
HERMAN, J. P. et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comprehensive Physiology, v. 6, n. 2, p. 603-621, 2016. doi: https://doi.org/10.1002/cphy.c150015.
HOSTETTMANN, K., WOLFENDER, J. Phytochemistry. In: Muller, W.E. (Ed.), St. John’s Wort and Its Active Principles in Depression and Anxiety. Birkhäuser Verlag, Basel, pp. 5–20, 2005.
* HRITCU, L.; NOUMEDEM, J.; CIOANCA, O. et al. Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1-42) rat model of Alzheimer's disease. Behavioral and Brain Functions, v. 11, n. 13, 2015. doi: 10.1186/s12993-015-0059-7. PMID: 25880991.
* ISLAM, M.; HASAN, J.; SNIGDHA, H et al. Chemical profile, traditional uses, and biological activities of Piper chaba Hunter: A review. Journal of Ethnopharmacology. v. 257, 112853, 2020. doi: 10.1016/j.jep.2020.112853. PMID: 32283191.
IMRAN, M.; SAMAL, M.; QADIR, A. A critical review on the extraction and pharmacotherapeutic activity of piperine. Polimers in Medicine. v. 52, n.1, p. 31-36, 2022. doi: 10.17219/pim/145512. PMID: 35196422.
JAREMA, M. Herbal drug treatment. Neuro Endocrinology Letters. v. 29, Suppl 1, p. 93-104, 2008. PMID: 19029875.
KAUR, G. et al. Anti-inflammatory and antioxidant potential of Piper betle Linn.: a review. Journal of Pharmacognosy and Phytochemistry, v. 5, n. 2, p. 355-360, 2016.
KUMAR, S. et al. Antidepressant activity of Piper longum fruit in mice: involvement of monoaminergic system. Journal of Ethnopharmacology, v. 137, n. 1, p. 318-324, 2011. doi: 10.1016/j.jep.2011.05.034
LAKHAN, S.E., VIEIRA, K.F. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutrition Journal, v. 9, art. 42, 2010. doi:10.1186/1475-2891-9-42. PMID: 20929532
LEE, S.A.; HWANG, J.S.; HAN, X.H. et al. Methylpiperate derivatives from Piper longum and their inhibition of monoamine oxidase. Archives of Pharmacal Research, v. 31, p. 679–683, 2008. https://doi.org/10.1007/s12272-001-1212-7
LEHRL, S. Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. Journal of Affective Disorders. v. 78, n.2, p.101-110, 2004. doi: 10.1016/s0165-0327(02)00238-0.
* LI Q.; QU F.; GAO Y.;et al. Piper sarmentosum Roxb. produces antidepressant-like effects in rodents, associated with activation of the CREB-BDNF-ERK signaling pathway and reversal of HPA axis hyperactivity. Journal of Ethnopharmacology, v. 199, p. 9-19, 2017. doi: 10.1016/j.jep.2017.01.037. PMID: 28126450.
* LI, S.; WANG, C.; WANG, M. et al . Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sciences, v. 80, p. 1373 – 1381, 2007. https://doi.org/10.1016/j.lfs.2006.12.027.
MALSCH, U.; KIESER, M. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Psychopharmacology, v.157, p. 277-283, 2001. https://doi.org/10.1007/s002130100792
* MAO, Q.; HUANG, Z.; ZHONG, X, et al. Piperine reverses chronic unpredictable mild stress-induced behavioral and biochemical alterations in rats. Cellular and Molecular Neurobiology. v. 34, n.3, p.403-408, 2014. doi: 10.1007/s10571-014-0025-1. PMID: 24401942
MENKE, ANDREAS. The HPA Axis as Target for Depression. Current Neuropharmacology, v. 22, p. 904 – 915, 2024.
Mehraj, S. et al. Piperine as an emerging antidepressant: evidence and mechanisms. Pharmacological Reports, v. 73, n. 4, p. 1125-1136, 2021. doi: https://doi.org/10.1007/s43440-021-00270-2
MONCRIEFF, J.; COOPER, R.; STOCKMANN, T. et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry, n. 28, p. 3243 – 3256, 2022.
MRNJAVAC, TAMARA (2012). "Is Kava (Piper Methysticum) Safe and Effective for Reducing Anxiety in Adult Patients 18-65?". PCOM Physician Assistant Studies Student Scholarship. Paper 83, 2012.
POPOVA, N., TSYBKO, A.; NAUMENKO; V. The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference. International Journal of Molecular Sciences, v. 23, n.15, 8814, 2022.
PRASHANTH, M.; REVANASIDDAPPA, H.; LOKANATHA, R. et al. Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues. Bioorganic & Medicinal Chemistry Letters, v. 22, p. 7065-7070, 2012. doi: 10.1016/j.bmcl.2012.09.089. PMID: 23079521.
QUESSEVEUR,G.; NGUYEN, H.; GARDIER, A.; GUIARD, B. 5-HT2 ligands in the treatment of anxiety and depression. Expert Opinion on Investigational Drugs, v. 21, n.11, p.1701–1725, 2012. doi: 10.1517/13543784.2012.719872 PMID: 22917059
REMES, O.; MENDES, J.; TEMPLETON, P. Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature. Brain Sciences, v. 11, n.12, 1633, 2021. doi: 10.3390/brainsci11121633. PMID: 34942936.
* REN, T.; ZUO, Z. Role of piperine in CNS diseases: pharmacodynamics, pharmacokinetics and drug interactions. Expert Opinion on Drug Metabolism and Toxicology, v. 15, n.10, p. 849-867, 2019. doi: 10.1080/17425255.2019.1672658. PMID: 31566028.
ROSS, S. Psychophytomedicine: an overview of clinical efficacy and phytopharmacology for treatment of depression, anxiety and insomnia. Holistic Nursing Practice, v. 28, n. 4, p. 275-280, 2014. doi: 10.1097/HNP.0000000000000040. PMID: 24919098.
* SANTOS SALES, V.; CABRAL, F., SALES, E. et al. Central depressant effects of Piper tuberculatum Jacq essential oil in mice. Food Bioscience, v. 48, 101813, 2022. https://doi.org/10.1016/j.fbio.2022.101813
SALEHI, B.; ZAKARIA, Z.; IBRAHIM, S. et al. Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications. Molecules, v. 24, 1364, 2019. doi: 10.3390/molecules24071364. PMID: 30959974
SARRIS, J.; KAVANAGH, D.J. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. Journal of Alternative and Complementary Medicine, v.15, n.8, p. 827-836, 2009. doi:10.1089/acm.2009.0066. PMID: 19614563.
* SARRIS, J.; KAVANAGH, D.; BYRNE, G. et al. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology (Berl). v. 205, n.3, p. 399-407, 2009. doi: 10.1007/s00213-009-1549-9. Epub 2009 May 9. PMID: 19430766.
SARRIS, J., et al. (2013). Kava for the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology, v. 33, n. 5, p. 643–648, 2013. doi: 10.1097/JCP.0b013e318291be67.
* SINGH, Y. Potential for interaction of kava and St. John's wort with drugs. Journal of Ethnopharmacology. v. 100, p. 108-113, 2005. doi: 10.1016/j.jep.2005.05.014. PMID: 16005588.
SONG, Y. S. et al. Anti-inflammatory effects of piperine in LPS-stimulated RAW 264.7 cells and endotoxin-shocked mice. Immunopharmacology and Immunotoxicology, v. 25, n. 3, p. 303-313, 2013. doi: https://doi.org/10.1081/IPH-120022443.
THAPAR, A.; EYRE, O.; PATEL, V. et al. Depression in young people. Lancet, v. 400, p. 617 – 631, 2022. doi: 10.1016/S0140-6736(22)01012-1 PMID: 35940184
TOMASETTI, C.; MONTEMITRO, C.; FIENGO, L.; SANTONE et al. Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System. Current Pharmaceutical Design, v.25, p. 381 – 387, 2019.
VALVASSORI, S.; VARELA, R.; QUEVEDO, J. Animal Models of Mood Disorders: Focus on Bipolar Disorder and Depression. Academic Press, 991-1002, 2017.
VAN DER WATT, G., LAUGHARNE, J., JANCA, A. Complementary and alternative medicine in the treatment of anxiety and depression. Current Opinion in Psychiatry, v. 21, n.1, p. 37-42, 2008. doi: 10.1097/YCO.0b013e3282f2d814. PMID: 18281839.
VENANCIO, E. et al. Anxiolytic- and antidepressant-like effects of the essential oil from the fruits of Piper nigrum L. in mice: involvement of serotoninergic but not GABAergic transmission system. Journal of Pharmacy and Pharmacology, v. 67, n. 7, p. 1040-1048, 2015. doi: 10.1111/jphp.12401
ZHANG, L.; LIU, C.; YUAN, M. et al. Piperlongumine produces antidepressant-like effects in rats exposed to chronic unpredictable stress. Behavioural Pharmacology, v. 30, p. 722 – 729, 2019. PMID: 31503069 DOI: 10.1097/FBP.0000000000000498
ZHOU, Y. et al. The hypothalamic-pituitary-adrenal axis in major depressive disorder: insights from clinical and basic research. Frontiers in Psychiatry, v. 10, p. 296, 2019. doi: https://doi.org/10.3389/fpsyt.2019.00296
XIE, H.; YAN, M.; JIN, D.; et al. Studies on antidepressant and antinociceptive effects o f ethyl acetate extract from Piper laetispicum and structure–activity relationship of its amide alkaloids. Fitoterapia, v. 82, p. 1086 – 1092, 2011. https://doi.org/10.1016/j.fitote.2011.07.006
* WATTANATHORN, J.; CHONPATHOMPIKUNLERT, P.; MUCHIMAPURA, S. et al. Piperine, the potential functional food for mood and cognitive disorders. Food And Chemical Toxicology, v. 46, p. 3106-3110, 2008. https://doi.org/10.1016/j.fct.2008.06.014
WEI, Q.; ZHOU, W.; ZHENG, J. et al. Antidepressant effects of 3-(3,4-methylenedioxy-5-trifluoromethyl phenyl)-2E-propenoic acid isobutyl amide involve TSPO-mediated mitophagy signalling pathway. Basic & Clinical Pharmacology & Toxicology. v. 127, p. 380-388, 2020. doi: 10.1111/bcpt.13452 PMID: 32511877
WHEATLEY, D (2005). Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. Journal of Psychopharmacology. v. 19, n.4, p. 414-421, 2005. doi: 10.1177/0269881105053309. PMID: 15982998
* WU, S.; WANG, R.; XUE, J.; PAN, J. Effect of piperine on 5-HT and synaptophysin expression of rats with irritable bowel syndrome. Yao Xue Xue Bao. v. 48, n. 12, p.1785-1791, 2013. Chinese. PMID: 24689235.
* YAO, C.; WAG, J,; DONG, D. et al. Laetispicine, an amide alkaloid from Piper laetispicum, presents antidepressant and antinociceptive effects in mice. Phytomedicine. v. 16, p. 823 – 829, 2009. https://doi.org/10.1016/j.phymed.2009.02.008
* YUN, Y.; NODA, S.; TAKAHASHI, S. et al. Piperine-like alkamides from Piper nigrum induce BDNF promoter and promote neurite outgrowth in Neuro-2a cells. Journal of Natural Medicines, v.72, n.1, p. 238-245, 2018. doi: 10.1007/s11418-017-1140-3. PMID: 29063362.
